These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28691157)

  • 61. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vigabatrin associated retinal dysfunction in children with epilepsy.
    Koul R; Chacko A; Ganesh A; Bulusu S; Al Riyami K
    Arch Dis Child; 2001 Dec; 85(6):469-73. PubMed ID: 11719329
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vigabatrin in childhood epilepsy.
    Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Epileptic seizures in childhood: from seizure type to diagnosis].
    Milh M; Ticus I; Villeneuve N; Hugonencq C; Mancini J; Chabrol B
    Arch Pediatr; 2008 Feb; 15(2):216-22. PubMed ID: 18248967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of vigabatrin in the management of infantile epileptic syndromes.
    Appleton RE
    Neurology; 1993 Nov; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Seizure control and educational outcome in childhood-onset epilepsy.
    Zelnik N; Sa'adi L; Silman-Stolar Z; Goikhman I
    J Child Neurol; 2001 Nov; 16(11):820-4. PubMed ID: 11732767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
    Humphrey A; Neville BG; Clarke A; Bolton PF
    Dev Med Child Neurol; 2006 Jul; 48(7):609-11. PubMed ID: 16780633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Epileptic spasms without hypsarrhythmia. A new case report and review of the literature].
    Navas-Sánchez P; Martínez-Antón J; Bauzano-Poley E
    Rev Neurol; 2010 Nov; 51(10):592-6. PubMed ID: 21069638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vigabatrin in childhood epilepsy: a 5-year follow-up study.
    Uldall P; Alving J; Gram L; Høgenhaven H
    Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
    Wirrell EC; Wong-Kisiel LC; Nickels KC
    Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D; Bogner M; Parker-Menzer K; Devinsky O
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G; Berz K; Holthausen H
    Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Population dose-response analysis of daily seizure count following vigabatrin therapy in adult and pediatric patients with refractory complex partial seizures.
    Nielsen JC; Hutmacher MM; Wesche DL; Tolbert D; Patel M; Kowalski KG
    J Clin Pharmacol; 2015 Jan; 55(1):81-92. PubMed ID: 25117853
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Symptomatic West's syndrome: specific etiological link to unexpected response to treatment].
    Caraballo R; Cersósimo R; Arroyo H; Fejerman N
    Rev Neurol; 1998 Mar; 26(151):372-5. PubMed ID: 9585945
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discontinuation of anticonvulsant medication after epilepsy surgery in children.
    Hoppe C; Poepel A; Sassen R; Elger CE
    Epilepsia; 2006 Mar; 47(3):580-3. PubMed ID: 16529625
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vigabatrin and psychosis.
    Sander JW; Hart YM; Trimble MR; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):435-9. PubMed ID: 1865207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
    Kälviäinen R; Aikiä M; Saukkonen AM; Mervaala E; Riekkinen PJ
    Arch Neurol; 1995 Oct; 52(10):989-96. PubMed ID: 7575227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.